No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13346231 |
chr19:36448006-36448007 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs528288839 |
chr19:36448016-36448017 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs546854269 |
chr19:36448026-36448027 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs568329382 |
chr19:36448082-36448083 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs535411849 |
chr19:36448091-36448092 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs557243785 |
chr19:36448107-36448108 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs192836214 |
chr19:36448163-36448164 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs539452445 |
chr19:36448165-36448166 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs56009137 |
chr19:36448174-36448175 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs557828778 |
chr19:36448189-36448190 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs28675882 |
chr19:36448272-36448273 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs386808967 |
chr19:36448291-36448292 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs73928370 |
chr19:36448294-36448295 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs555571863 |
chr19:36448300-36448301 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs574200617 |
chr19:36448308-36448309 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs11880325 |
chr19:36448334-36448335 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs563204240 |
chr19:36448365-36448366 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs35742682 |
chr19:36448398-36448399 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs397768211 |
chr19:36448411-36448412 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs575081846 |
chr19:36448414-36448415 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs34915088 |
chr19:36448509-36448510 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs564158240 |
chr19:36448545-36448546 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs185774752 |
chr19:36448565-36448566 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs147325869 |
chr19:36448638-36448639 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs79698216 |
chr19:36448731-36448732 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs532471436 |
chr19:36448732-36448733 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs529099714 |
chr19:36448741-36448742 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs367903055 |
chr19:36448797-36448798 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs550555603 |
chr19:36448833-36448834 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs4806238 |
chr19:36448842-36448843 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs539438349 |
chr19:36448863-36448864 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs551395652 |
chr19:36448889-36448890 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs11673051 |
chr19:36448921-36448922 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs77084233 |
chr19:36448934-36448935 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs142980630 |
chr19:36448983-36448984 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs577172579 |
chr19:36449011-36449012 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572863253 |
chr19:36449084-36449085 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs190504275 |
chr19:36449125-36449126 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs544862440 |
chr19:36449135-36449136 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538435442 |
chr19:36449146-36449147 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs150814723 |
chr19:36449178-36449179 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs578224715 |
chr19:36449216-36449217 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs545797476 |
chr19:36449261-36449262 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs564098926 |
chr19:36449336-36449337 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs572897421 |
chr19:36449344-36449345 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs79509161 |
chr19:36449350-36449351 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs561830405 |
chr19:36449501-36449502 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs112818730 |
chr19:36449506-36449507 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs563054735 |
chr19:36449569-36449570 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs193239016 |
chr19:36449654-36449655 |
Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|